Two Seas Capital »

SPDR S&P Biotech shares owned by Two Seas Capital

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Two Seas Capital from 13F filings

Historical chart of Two Seas Capital investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Two Seas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Two Seas Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $246M 1.9M 127.73

More positions owned by Two Seas Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Core Scientific (CORZ)
Roivant Sciences SHS (ROIV)
Spdr Series Trust State Street Spd Put Option (XBI)
Apple Put Option (AAPL)
Calumet (CLMT)
Talen Energy Corp (TLN)
First Solar (FSLR)
Indivior Pharmaceuticals (INDV)
Nektar Therapeutics Com New (NKTR)
Gannett (TDAY)
Sable Offshore Corp Com Shs (SOC)
Echostar Corp Cl A (SATS)
Sotera Health (SHC)
Arbutus Biopharma (ABUS)

View all positions for Two Seas Capital

Top funds holding SPDR S&P Biotech

Bnp Paribas Arbitrage, Snc
Susquehanna International
Bank of America Corporation
Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Morgan Stanley
Citigroup
Deep Track Capital
Jane Street
Citadel Advisors
UBS Group
Wells Fargo & Company
Barclays
Leucadia National Corporation
Jain Global

View all funds holding SPDR S&P Biotech